TIFFANY OSBORNE: Open Payments
NPI 1932748480 · FITCHBURG, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 9 payments from 7 companies in 2025. Trend: 2023 $58 · 2024 $567 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $117 |
| Neurocrine BioSciences, Inc. | 1 | $110 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| ABBVIE INC. | 1 | $24 |
| UCB, Inc. | 1 | $23 |
| ARGENX US, INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
Products named: SPRAVATO, INGREZZA, COBENFY, VRAYLAR, Briviact, VYVGART, AMYVID.
Industry payments across MA — which companies pay providers there.
